Dysregulation of CDK Inhibitors and p53 in HPV-negative Endocervical Adenocarcinoma
- 1 March 2015
- journal article
- pathology of-the-lower-genital-tract
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 34 (2) , 196-203
Abstract
Human papillomavirus (HPV)-negative adenocarcinoma (AC) is a minor subset of endocervical cancer, but its pathogenesis has yet to be elucidated. This study investigated the clinicopathologic features of HPV-negative endocervical AC (n=14) in comparison with HPV-positive endocervical AC (n=30), and further studied aberrations of cell-cycle regulators. Expression patterns of cyclin-dependent kinase inhibitors (p16, p14, p27, and p21) and p53 were evaluated immunohistochemically, and nuclear high-risk HPV DNA signals were detected by in situ hybridization and polymerase chain reaction. Immunoexpression of p16, p14, p27, p21, and p53 were observed in 90%, 67%, 77%, 40%, and 20% of HPV-positive ACs, and in 0%, 0%, 29%, 14%, and 57% of HPV-negative ACs, respectively. A higher frequency of lymph node metastasis and worse prognosis were significantly associated with HPV-negative AC. Our findings suggest that alteration of cyclin-dependent kinase inhibitors and p53 status may contribute to carcinogenesis and the clinical behavior of HPV-negative AC of the uterine cervix.Keywords
This publication has 34 references indexed in Scilit:
- Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 yearsThe Lancet, 2009
- Etiologic Heterogeneity for Cervical Carcinoma by Histopathologic Type, Using Comparative Age-Period-Cohort ModelsCancer Epidemiology, Biomarkers & Prevention, 2009
- Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for ScreeningObstetrics & Gynecology, 2004
- Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000Cancer, 2004
- The causal relation between human papillomavirus and cervical cancerJournal of Clinical Pathology, 2002
- Alteration of Cell Cycle in Cervical Tumor Associated with Human Papillomavirus: Cyclin-Dependent Kinase InhibitorsYonsei Medical Journal, 2002
- Prevalence of Human Papillomavirus DNA in Different Histological Subtypes of Cervical AdenocarcinomaThe American Journal of Pathology, 2000
- Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in CarcinogenesisJNCI: Journal of the National Cancer Institute, 2000
- Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasiaPathology International, 1998
- Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.Proceedings of the National Academy of Sciences, 1996